4596.T
Price:
$51
Market Cap:
$3.02B
Kubota Pharmaceutical Holdings Co., Ltd. develops portfolio of drugs and devices worldwide. Its product pipeline comprises emixustat hydrochloride, which is in Phase III clinical stage used for the treatment of stargardt disease, and Phase II clinical stage used for the treatment of proliferative diabetic retinopathy. The company is also developing remote retinal monitoring device patient-based ophthalmology suite, that includes home-based miniature and NASA high-res version optical coherence tomography devices; and wearable device for myopia control. The company was founded in 2002 and is based in Tokyo, Japan.
Industry
Biotechnology
IPO Date
2016-12-06
Stock Exchange
JPX
Ticker
4596.T
According to Kubota Pharmaceutical Holdings Co., Ltd.’s latest financial reports and current stock price. The company's current ROE is -78.96%. This represents a change of 290.40% compared to the average of -20.22% of the last 4 quarters.
The mean historical ROE of Kubota Pharmaceutical Holdings Co., Ltd. over the last ten years is -57.47%. The current -78.96% ROE has changed 37.38% with respect to the historical average. Over the past ten years (40 quarters), 4596.T's ROE was at its highest in in the December 2022 quarter at -8.48%. The ROE was at its lowest in in the December 2024 quarter at -23.97%.
Average
-57.47%
Median
-53.66%
Minimum
-95.91%
Maximum
-37.95%
Discovering the peaks and valleys of Kubota Pharmaceutical Holdings Co., Ltd. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 70.42%
Maximum Annual ROE = -37.95%
Minimum Annual Increase = -18.99%
Minimum Annual ROE = -95.91%
Year | ROE | Change |
---|---|---|
2024 | -95.91% | 70.42% |
2023 | -56.28% | 10.25% |
2022 | -51.04% | -18.99% |
2021 | -63.00% | 54.91% |
2020 | -40.67% | 7.16% |
The current ROE of Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-67.74%
5-year avg
-61.38%
10-year avg
-57.47%
Kubota Pharmaceutical Holdings Co., Ltd.’s ROE is
Company | ROE | Market cap |
---|
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kubota Pharmaceutical Holdings Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Kubota Pharmaceutical Holdings Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Kubota Pharmaceutical Holdings Co., Ltd.'s ROE?
How is the ROE calculated for Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)?
What is the highest ROE for Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)?
What is the 3-year average ROE for Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)?
What is the 5-year average ROE for Kubota Pharmaceutical Holdings Co., Ltd. (4596.T)?
How does the current ROE for Kubota Pharmaceutical Holdings Co., Ltd. (4596.T) compare to its historical average?